Interventional Cardiology Devices – Market Insights – Asia Pacific

Although the global COVID-19 pandemic negatively impacted the Asia Pacific IC market in 2020, the market has shown strong recovery and will resume prepandemic growth trends in the near term. Going forward, the Asia Pacific IC device market will expand moderately, fueled by expansion of the coronary stents, balloons and intravascular imaging and pressure guidewire markets.

This Medtech 360 Report provides comprehensive data and analysis on the state of the interventional cardiology device market in Asia Pacific from 2019 through 2032.

A number of innovations are upcoming in the highly competitive DES market.

What are some notable innovations in the DES market? How are these devices expected to perform in the existing DES market?

Which clinical studies are likely to influence the upcoming developments in the DES market?

Which DES devices are in the pipeline to enter the market through the forecast period?

How is the BRS segment performing in the Asia Pacific market?

Will the BRS market grow as well as DES?

Emerging technologies such as FFRCT, resting-state FFR, and angiography-based FFR will influence the IC diagnostic landscape in the countries covered.

How will the adoption of alternative coronary physiology modalities such as resting indices, angiography-based FFR, and noninvasive FFRCT alter patient and procedure compositions in cardiac catheterization labs?

How will the emergence of alternative FFR modalities affect the FFR pressure guidewire market?

How is the uptake of noninvasive imaging technologies in the Asia Pacific IC device market?

The Asia Pacific IC device market is characterized by the presence of several domestic manufacturers.

In which segments are domestic manufacturers challenging the positions of the international manufacturers, and how?

What competitive strategies are the major companies implementing to gain market share in this market?

What strategies can new competitors employ to gain entry into the Asia Pacific coronary stent market?

Demographic, reimbursement, and regulatory factors differ by country, resulting in varying market landscapes.

Which countries will present the greatest opportunity for manufacturers, and why?

How are regulatory changes impacting the Asia Pacific IC markets?

What difficulties will manufacturers need to overcome in order to be successful in each country?

The Asia Pacific IC device market has been impacted by the COVID-19 pandemic.

What is the recovery outlook for 2022 and going forward?

Table of contents